NCT06425237

Brief Summary

Cerebral arteriography is a reference examination in medical imaging. This examination is performed to allow the diagnosis and therapeutic management of patients with vascular pathologies. It is most often accompanied by a situation of stress, anxiety and apprehension related to the course of the examination or the announcement of the results. These situations generate physiological reactions in patients, making the performance of cerebral arteriography more complex. In order to improve the quality of care for patients undergoing this invasive examination, it is proposed to use two non-medicinal techniques known for their soothing and relaxing properties: aromatherapy and music therapy alone or in combination. These two techniques will help to establish a common thread from the preparation of the patient before the examination to his return to the post-interventional surveillance room.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
224

participants targeted

Target at P75+ for not_applicable

Timeline
19mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
Nov 2024Nov 2027

First Submitted

Initial submission to the registry

April 9, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 22, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

November 4, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2027

Last Updated

September 11, 2025

Status Verified

September 1, 2025

Enrollment Period

3 years

First QC Date

April 9, 2024

Last Update Submit

September 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • influence of aromatherapy and music therapy on the patient's stress when undergoing cerebral arteriography.

    blood pressure

    day 1

Secondary Outcomes (4)

  • stress

    day 1

  • level of pain

    day 1

  • hospital anxiety and depression scale

    day 1

  • Cumulative X-ray dose (mGy/cm2) received by the patient

    day 1

Study Arms (4)

standard care

NO INTERVENTION

standard care and music therapy

EXPERIMENTAL
Other: music therapy

standard care and aromatherapy

EXPERIMENTAL
Other: aromatherapy

standard care ansd music therapy and aromatherapy

EXPERIMENTAL
Other: music therapyOther: aromatherapy

Interventions

standard patient care in interventional radiology associated with a well-being atmosphere with the implementation of music therapy (soothing sound environment) in the preparation box and in the examination room.

standard care and music therapystandard care ansd music therapy and aromatherapy

standard patient care in interventional radiology associated with a well being atmosphere with the implementation of aromatherapy (essential oil of Ylang Ylang) in the preparation box and in the examination room.

standard care and aromatherapystandard care ansd music therapy and aromatherapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (≥ 18 years old)
  • Patient who is scheduled for a cerebral arteriography with local anaesthesia
  • Patient who capable to read and understand the patient information and consent.
  • Patient capable to read and sign the consent form
  • Patient with social insurance
  • Woman of childbearing age with effective contraception (see WHO definition), postmenopausal woman (≥ 12 months of amenorrhea not induced by therapy)
  • Negative urine pregnancy test

You may not qualify if:

  • Patients who have had a previous cerebral arteriogram
  • Patient with allergy to iodinated contrast medium
  • Patient with severe renal insufficiency
  • Patient requiring sedation and artificial ventilation
  • Patient who is deaf and/or hard of hearing
  • Patient with a known allergy to essential oils
  • Patient with anosmia
  • Person deprived of liberty by an administrative or judicial decision or person placed under judicial protection, under guardianship or curatorship,
  • Pregnant or breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de ROUEN

Rouen, 76 000, France

RECRUITING

MeSH Terms

Interventions

Music TherapyAromatherapy

Intervention Hierarchy (Ancestors)

Sensory Art TherapiesComplementary TherapiesTherapeuticsRehabilitationAftercareContinuity of Patient CarePatient CarePsychotherapyBehavioral Disciplines and ActivitiesMind-Body TherapiesPhytotherapy

Study Officials

  • Magali DUVAL, radiology technician

    CHU Rouen

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Magali DUVAL, radiology technician

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 9, 2024

First Posted

May 22, 2024

Study Start

November 4, 2024

Primary Completion (Estimated)

November 4, 2027

Study Completion (Estimated)

November 4, 2027

Last Updated

September 11, 2025

Record last verified: 2025-09

Locations